Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Suxamethonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 0.95 |
| ▸ | BLM | P54132 | 1/20 | 0.95 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.65 |
| ▸ | CHRM3 | P20309 | 8/20 | 0.65 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.65 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.65 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.65 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.65 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.65 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.65 |
| ▸ | HTR1A | P08908 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | PGR | P06401 | 1/20 | 0.65 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.65 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.65 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.65 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Suxamethonium SCHEMBL41536 | 0.97 | MAPT (1.00) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL2690356 | 0.97 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL21356923 | 0.97 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL16320883 | 0.97 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL1643328 | 0.97 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL2821312 | 0.97 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL20815392 | 0.95 | MAPT (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL1983256 | 0.95 | MAPT (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL12560604 | 0.91 | ADRA2A (0.83) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL357905 | 0.91 | ADRA2A (0.83) | ADRA2AADRA1AMAPTBLMCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9705 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719552-A1 | INDUCTION OF GENERAL ANESTHESIA IN ADULTS UNDERGOING ELECTIVE SURGERY | Xizang Haisco Pharmaceutical Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| EP-4076560-B1 | SURFACE MODIFYING COATING FOR MEDICAL DEVICES | HOSPIRA INC (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4221200-B1 | DEVICE AND METHOD FOR CODING VIDEO DATA BASED ON ONE OR MORE REFERENCE LINES | SHARP KK (JP) | 2026-03-04 | — | — | EP | claimed |
| US-20260000678-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING, SUPPRESSING, OR TREATING SYMPTOM ASSOCIATED WITH PSEUDO-ALLERGIC REACTION | TAKASAKI UNIV OF HEALTH AND WELFARE (JP) | 2026-01-01 | — | — | US | claimed |
| EP-4655448-A1 | OBJECT, METHOD FOR FUNCTIONALIZING AN OBJECT AND OBJECT WHICH CAN BE OBTAINED THEREFROM, AND METHOD FOR BINDING A PEPTIDE, AND USE OF AN OBJECT FOR BINDING A PEPTIDE | Wenatex Forschung - Entwicklung - Produktion GmbH (AT) | 2025-12-03 | — | — | EP | claimed |
| US-12403262-B2 | Tamper evident assembly with RFID for syringes | FRESENIUS KABI USA, LLC (US) | 2025-09-02 | — | — | US | claimed |
| US-20250249185-A1 | TAMPER EVIDENT CAP WITH RFID FOR SYRINGES | FRESENIUS KABI USA, LLC | 2025-08-07 | — | — | US | claimed |
| US-20250243208-A1 | BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS | INCYTE CORPORATION | 2025-07-31 | — | — | US | claimed |
| EP-4249494-B1 | A DRUG COMPRISING A RADICAL GENERATING CATALYST | ACENET INC (JP) | 2025-07-16 | — | — | EP | claimed |
| US-20250206734-A1 | BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS | INCYTE CORPORATION | 2025-06-26 | — | — | US | claimed |
| EP-0575479-A1 | PRODUCTION AND USE OF BUTYRYLCHOLINESTERASE | PHARMAVENE, INC. (US) | 1993-12-29 | — | — | EP | claimed |
| WO-1993001830-A1 | EXPRESSION OF ENZYMATICALLY ACTIVE RECOMBINANT HUMAN ACETYLCHOLINESTERASE AND USES THEREOF | BIO-TECHNOLOGY GENERAL CORP. (US) | 1993-02-04 | — | — | WO | claimed |
| WO-1992014483-A1 | PRODUCTION AND USE OF BUTYRYLCHOLINESTERASE | PHARMAVENE, INC. (US) | 1992-09-03 | — | — | WO | claimed |
| EP-0126684-B1 | DRUG DELIVERY SYSTEM UTILIZING THERMOSETTING GELS | MERCK & CO. INC. (US) | 1991-08-28 | — | — | EP | claimed |
| EP-0388906-A2 | Genetically engineered human cholinesterases | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1990-09-26 | — | — | EP | claimed |
| US-4726594-A | Drug injection system for use with an arrow | BENKE GUS A (US) | 1988-02-23 | — | — | US | claimed |
| EP-0206200-A2 | Human cholinesterase-type proteins and their production | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1986-12-30 | — | — | EP | claimed |
| EP-0147780-A2 | Drug delivery device | MERCK & CO. INC. (US) | 1985-07-10 | — | — | EP | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| US-4474752-A | DIAMINE MODIFIED POLYOXYETHYLENE-POLYOXYPROPYLENE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |